Support program for people newly diagnosed with retinitis pigmentosa
Part of Eyes & vision, Genetic & congenital clinical trials.
This study is testing a new way to support people who have just been told they have retinitis pigmentosa (RP) at the Quinze-Vingts hospital in Paris. It aims to help you understand your diagnosis and get the care you need.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with retinitis pigmentosa (RP) at the Quinze-Vingts Rare Eye Disease Center since the study started.
- You are between 18 and 65 years old.
- You speak French.
- You have a phone number and live in France.
- You are not pregnant.
- You have not been in another clinical trial in the past 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new peptide therapy for people with retinitis pigmentosa (RP), a genetic eye disease that causes vision loss. The goal is to see if the treatment is safe and can help slow or improve vision loss.
This trial tests a new gene therapy injection (ZM-02) that uses light-sensitive proteins to help restore vision in people with advanced retinitis pigmentosa. It’s designed to see if the treatment is safe and can improve vision.
This trial tests a gentle laser treatment (SML) for people with retinitis pigmentosa (RP), an inherited eye disease that slowly causes vision loss. The goal is to see if the laser can help slow or improve vision problems like night blindness and tunnel vision.
This study tests a new eye injection containing pitavastatin, a drug normally used for cholesterol, wrapped in tiny particles. The goal is to see if it is safe and if it can help slow vision loss in people with retinitis pigmentosa.
This trial tests a gene therapy injection (UGX202) for people with advanced retinitis pigmentosa (RP) who have very poor vision. It aims to see if the treatment can help improve or preserve sight.
This study looks at how well people with vision loss can do everyday tasks at home and in public. Researchers want to find better ways to measure how vision problems affect mobility, so they can help people live more independently.
Hear when a new Retinitis Pigmentosa (RP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.